机译:P2.01-107 CTDNA在肺腺癌患者转移位点的突变检测分析
Oncology Jiangsu Province Hospital;
Geneplus-Beijing;
State Key Laboratory of Respiratory Disease guangzhou Institute of Respiratory Disease The First;
Shanghai Chest Hospital;
Cancer Center Union Hospital Tongji Medical College Huazhong University of Science and Technology;
Thoracic Oncology Beijing Cancer Hospital;
Department of Medical Oncology Tongji Hospital Tongji Medical College Huazhong University of;
Nan Jing Drum Tower Hospital;
Geneplus-Beijing;
Geneplus-Beijing;
机译:P2.01-107 CTDNA在肺腺癌患者转移位点的突变检测分析
机译:P2.01-100富含循环肿瘤DNA富集的不同遗传突变预测肺腺癌患者的不同转移性位点
机译:KRAS突变的发生率和预后价值在肺腺癌中是转移部位特异性的:KRAS突变和骨转移的患者预后较差
机译:肺腺癌的EGFR突变:与F-18 FDG PET / CT的相关性
机译:与表皮生长因子受体基因激活突变有关的肺腺癌疾病病程特征。
机译:循环肿瘤DNA(CTDNA)中的下一代测序(NGS)评估的突变简谱评估肺腺癌患者:现实世界数据分析
机译:EP1.01-66在组织肺腺癌中血液和尿液中基因组突变的检测 - 临时进度报告